-
Industry Symposium 1
Antibody-Drug Conjugates: New Approaches in Platinum-Resistant Ovarian Cancer
organized by Abbvie
Thursday, February 20, 2025 │ 12:30 – 13:30
-
Industry Symposium 2
organized by MSD
Friday, February 21, 2025 │11:00 – 12:00
-
Industry Symposium 3
PARPi: New Horizons in Patients with Advanced Ovarian Cancer
Bringing Evidence to Patient Careorganized by pharma&
Friday, February 21, 2025 │ 11:00 – 12:00
-
Industry Symposium 4
Personalising Long-term PARPi Monotherapy for aOC Patients with an Optimal Response to Platinum
organized by GSK
Friday, February 21, 2025 │ 13:50 – 14:50
-
Industry Symposium 5
Navigating the Complexity of Advanced & Recurrent Endometrial Cancer: Optimizing Management and Treatment of Disease
organized by AstraZeneca
Saturday, February 22, 2025 │ 11:30 – 12:30
-
Industry Symposium 6
Contextualising New First-Line Ovarian Cancer Data: How Will this Impact Personalised Treatment Strategies?
organized by AstraZeneca
Saturday, February 22, 2025 │ 14:20 – 15:20
Register
- Home
- Partners & Exhibition
- Industry Sessions